Please use this identifier to cite or link to this item:
|Title:||Clinical trials and management of osteochondral lesions|
|Author(s):||Vilela, Carlos A.|
da Silva Morais, Alain
Pina, Sandra Cristina Almeida
Oliveira, J. M.
Correlo, V. M.
Reis, R. L.
|Journal:||Advances in Experimental Medicine and Biology|
|Citation:||Vilela C. A., da Silva Morais A., Pina S., Oliveira J. M., Correlo V. M., Reis R. L., Espregueira-Mendes J. Clinical Trials and Management of Osteochondral Lesions, Osteochondral Tissue Engineering. Advances in Experimental Medicine and Biology, Vol. 1058, pp. 391-413, doi:10.1007/978-3-319-76711-6_18, 2018|
|Abstract(s):||Osteochondral lesions are frequent and important causes of pain and disability. These lesions are induced by traumatic injuries or by diseases that affect both the cartilage surface and the subchondral bone. Due to the limited cartilage ability to regenerate and self-repair, these lesions tend to gradually worsen and progress towards osteoarthritis. The clinical, social, and economic impact of the osteochondral lesions is impressive and although therapeutic alternatives are under discussion, a consensus is not yet been achieved. Over the previous decade, new strategies based on innovative tissue engineering approaches have been developed with promising results. However, in order those products reach the market and help the actual patient in an effective manner, there is still a lot of work to be done. The current state of the implications, clinical aspects, and available treatments for this pathology, as well as the ongoing preclinical and clinical trials are presented in this chapter.|
|Access:||Restricted access (UMinho)|
|Appears in Collections:|
Files in This Item:
|19551-vilela2018_Clinical Trials and Management of Osteochondral Lesions.pdf|
|879,53 kB||Adobe PDF||View/Open|